Sergio Carmona to HIV-1
This is a "connection" page, showing publications Sergio Carmona has written about HIV-1.
Connection Strength
4,286
-
Assessment of the performance of the plasma separation card for HIV-1 viral load monitoring in South Africa. J Clin Microbiol. 2024 Apr 10; 62(4):e0164923.
Score: 0,504
-
A multi-center study comparing the analytical sensitivity and clinical concordance of three HIV-1 viral load assays. J Virol Methods. 2022 02; 300:114373.
Score: 0,429
-
Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):1187-1195.
Score: 0,421
-
Classification of HIV-1 virological treatment failure using the Roche cobas plasma separation card on cobas 8800 compared to dried blood spots on Abbott RealTime HIV-1. J Clin Virol. 2021 07; 140:104839.
Score: 0,412
-
Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load. J Clin Microbiol. 2019 04; 57(4).
Score: 0,357
-
Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. J Infect Dis. 2016 Dec 15; 214(12):1826-1830.
Score: 0,302
-
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
Score: 0,300
-
Improved Sensitivity of a Dual-Target HIV-1 Qualitative Test for Plasma and Dried Blood Spots. J Clin Microbiol. 2016 07; 54(7):1877-1882.
Score: 0,293
-
HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018. Pediatr Infect Dis J. 2023 04 01; 42(4):e102-e104.
Score: 0,116
-
The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis. PLoS Med. 2022 08; 19(8):e1004076.
Score: 0,113
-
Cost and Impact of Dried Blood Spot Versus Plasma Separation Card for Scale-up of Viral Load Testing in Resource-limited Settings. Clin Infect Dis. 2020 03 03; 70(6):1014-1020.
Score: 0,095
-
Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis. Clin Infect Dis. 2017 Nov 29; 65(12):2018-2025.
Score: 0,081
-
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018 02; 18(2):188-197.
Score: 0,081
-
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation. PLoS One. 2017; 12(7):e0181357.
Score: 0,080
-
Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges. J Int AIDS Soc. 2017 04 10; 20(1):21436.
Score: 0,078
-
Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey. PLoS One. 2016; 11(12):e0166305.
Score: 0,076
-
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLoS One. 2015; 10(12):e0145772.
Score: 0,071
-
Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa. J Clin Microbiol. 2015 May; 53(5):1616-21.
Score: 0,067
-
High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa. PLoS One. 2015; 10(2):e0118145.
Score: 0,067
-
Design and implementation of an external quality assessment program for HIV viral load measurements using dried blood spots. J Clin Microbiol. 2015 Mar; 53(3):964-6.
Score: 0,066
-
High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen. PLoS One. 2014; 9(5):e97067.
Score: 0,064
-
Viral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa. AIDS Res Hum Retroviruses. 2014 Mar; 30(3):289-93.
Score: 0,062
-
Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay. J Clin Microbiol. 2009 Oct; 47(10):3400-2.
Score: 0,046
-
Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag. AIDS Res Hum Retroviruses. 2006 May; 22(5):401-10.
Score: 0,037
-
Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa. J Acquir Immune Defic Syndr. 2020 04 01; 83(4):390-396.
Score: 0,024
-
Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study. Lancet HIV. 2019 11; 6(11):e760-e768.
Score: 0,023
-
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. EBioMedicine. 2017 Apr; 18:225-235.
Score: 0,019